BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24242705)

  • 1. Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.
    Larson SR; Chin J; Zhang X; Brown LG; Coleman IM; Lakely B; Tenniswood M; Corey E; Nelson PS; Vessella RL; Morrissey C
    Clin Exp Metastasis; 2014 Feb; 31(2):247-56. PubMed ID: 24242705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.
    Kirschenbaum A; Liu XH; Yao S; Leiter A; Levine AC
    Ann N Y Acad Sci; 2011 Nov; 1237():64-70. PubMed ID: 22082367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.
    Kirschenbaum A; Izadmehr S; Yao S; O'Connor-Chapman KL; Huang A; Gregoriades EM; Yakar S; Levine AC
    Endocrinology; 2016 Dec; 157(12):4526-4533. PubMed ID: 27783536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.
    Morrissey C; Lai JS; Brown LG; Wang YC; Roudier MP; Coleman IM; Gulati R; Vakar-Lopez F; True LD; Corey E; Nelson PS; Vessella RL
    Prostate; 2010 Mar; 70(4):412-24. PubMed ID: 19866469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
    Dai J; Keller J; Zhang J; Lu Y; Yao Z; Keller ET
    Cancer Res; 2005 Sep; 65(18):8274-85. PubMed ID: 16166304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer cells promote osteoblastic bone metastases through Wnts.
    Hall CL; Bafico A; Dai J; Aaronson SA; Keller ET
    Cancer Res; 2005 Sep; 65(17):7554-60. PubMed ID: 16140917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.
    Elshafae SM; Dirksen WP; Alasonyalilar-Demirer A; Breitbach J; Yuan S; Kantake N; Supsavhad W; Hassan BB; Attia Z; Alstadt LB; Rosol TJ
    Prostate; 2020 Jun; 80(9):698-714. PubMed ID: 32348616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.
    Larson SR; Zhang X; Dumpit R; Coleman I; Lakely B; Roudier M; Higano CS; True LD; Lange PH; Montgomery B; Corey E; Nelson PS; Vessella RL; Morrissey C
    Prostate; 2013 Jun; 73(9):932-40. PubMed ID: 23334979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer.
    Fradet A; Sorel H; Depalle B; Serre CM; Farlay D; Turtoi A; Bellahcene A; Follet H; Castronovo V; Clézardin P; Bonnelye E
    PLoS One; 2013; 8(9):e75092. PubMed ID: 24069383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
    Kitagawa Y; Dai J; Zhang J; Keller JM; Nor J; Yao Z; Keller ET
    Cancer Res; 2005 Dec; 65(23):10921-9. PubMed ID: 16322239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
    Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
    Zayzafoon M; Abdulkadir SA; McDonald JM
    J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.
    Raheem O; Kulidjian AA; Wu C; Jeong YB; Yamaguchi T; Smith KM; Goff D; Leu H; Morris SR; Cacalano NA; Masuda K; Jamieson CH; Kane CJ; Jamieson CA
    J Transl Med; 2011 Oct; 9():185. PubMed ID: 22035283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
    Ganguly SS; Hostetter G; Tang L; Frank SB; Saboda K; Mehra R; Wang L; Li X; Keller ET; Miranti CK
    Oncogene; 2020 Jan; 39(1):204-218. PubMed ID: 31467432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo-osteogenic balance in bone marrow.
    Wang C; Wang J; Chen K; Pang H; Li X; Zhu J; Ma Y; Qiu T; Li W; Xie J; Zhang J
    Cancer Sci; 2020 Oct; 111(10):3600-3612. PubMed ID: 32770813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.
    Dai J; Kitagawa Y; Zhang J; Yao Z; Mizokami A; Cheng S; Nör J; McCauley LK; Taichman RS; Keller ET
    Cancer Res; 2004 Feb; 64(3):994-9. PubMed ID: 14871830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase.
    Quiroz-Munoz M; Izadmehr S; Arumugam D; Wong B; Kirschenbaum A; Levine AC
    J Endocr Soc; 2019 Mar; 3(3):655-664. PubMed ID: 30842989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts.
    Shokoohmand A; Ren J; Baldwin J; Atack A; Shafiee A; Theodoropoulos C; Wille ML; Tran PA; Bray LJ; Smith D; Chetty N; Pollock PM; Hutmacher DW; Clements JA; Williams ED; Bock N
    Biomaterials; 2019 Nov; 220():119402. PubMed ID: 31400612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.